Profile data is unavailable for this security.
About the company
BioPharma Credit PLC is a United Kingdom-based specialist debt investor to the life sciences industry. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. It seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products. The Company may also invest in equity issued by a life sciences company, acquired directly from the life sciences company or in the secondary market. It will seek to create a diversified portfolio of investments by investing across a range of different forms of debt assets issued by a variety of borrowers. It has two wholly owned subsidiaries: BPCR Limited Partnership and BPCR GP Limited. The Company holds a majority of its investments through its financing subsidiary, BPCR Limited Partnership. Its investment manager is Pharmakon Advisors, LP.
- Revenue in USD (TTM)136.36m
- Net income in USD109.36m
- Incorporated2016
- Employees11.00
- LocationBioPharma Credit PLC51 New North RoadEXETER EX4 4EPUnited KingdomGBR
- Phone+44 139 247 7503
- Websitehttp://bpcruk.com/#
Profile
| Management group(s) | Pharmakon Advisors L.P. |
|---|---|
| AIC sector | Debt - Direct Lending |
| ISIN | GB00BDGKMY29 |
| Launch date | 27 Mar 2017 |
| Share type | Ordinary Share |
| Structure | Investment Trust |
| Base currency | USD |
Objective
To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company will seek to achieve its investment objective predominantly through direct or indirect exposure to Debt Assets, which include Royalty Investments, Senior Secured Debt, Unsecured Debt and Credit Linked Notes.
Managed by
| Pedro Gonzalez de Cosio, Pablo Legorreta, Martin Friedman |
|---|
Management & contract fees
Annual management fee is 1% of NAV. The performance fee is calculated as 10% of returns, subject to High Watermark and a 6% preferred return hurdle with 50% catch up.
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Syncona Ltd | 41.13m | 5.07m | 951.48m | 0.00 | 173.13 | 0.5999 | -- | 23.14 | 0.0066 | 0.0066 | 0.0461 | 1.89 | 0.0244 | -- | 3.19 | -- | 0.3007 | -2.82 | 0.3035 | -2.85 | -- | -- | 12.32 | -- | -- | -- | 0.00 | -- | 177.28 | -41.24 | 106.76 | -60.84 | -- | -- |
| Temple Bar Investment Trust PLC | 220.52m | 208.21m | 983.93m | 0.00 | 5.01 | 0.973 | 4.73 | 4.46 | 0.5347 | 0.5347 | 0.5645 | 2.75 | 0.2006 | -- | 29.11 | -- | 18.94 | 3.82 | 19.01 | 3.86 | 96.67 | 83.80 | 94.42 | 78.33 | -- | -- | 0.0865 | 85.55 | 1,320.23 | -- | 643.71 | -- | -- | 38.72 |
| Schroder AsiaPacific Fund plc | 17.12m | -1.44m | 992.29m | 0.00 | -- | 0.9683 | -- | 57.95 | -0.0013 | -0.0013 | 0.0828 | 5.69 | 0.014 | -- | 4.46 | -- | -0.1177 | 3.73 | -0.1209 | 3.81 | 42.26 | 84.23 | -8.40 | 75.49 | -- | -- | 0.00 | 47.83 | 125.73 | -5.49 | 115.41 | -8.68 | -- | 4.78 |
| JPMorgan Japanese Investment Trust PLC | 189.39m | 177.68m | 1.01bn | 0.00 | 6.20 | 0.9406 | -- | 5.31 | 0.8973 | 0.8973 | 0.9422 | 5.91 | 0.1526 | -- | 24.74 | -- | 14.32 | 0.0424 | 14.61 | 0.0428 | 95.73 | 28.61 | 93.82 | 4.99 | -- | -- | 0.0726 | 1,961.78 | 115.52 | -20.11 | 113.07 | -21.81 | -- | 5.39 |
| Global Smaller Companies Trust PLC | 101.61m | 90.40m | 1.03bn | 0.00 | 12.29 | 0.9507 | -- | 10.10 | 0.136 | 0.136 | 0.1479 | 1.76 | 0.0824 | -- | 8.85 | -- | 7.33 | 5.00 | 7.51 | 5.11 | 92.42 | 89.42 | 88.97 | 86.06 | -- | -- | 0.0559 | 24.18 | 336.76 | 14.25 | 270.00 | 16.55 | -- | 11.24 |
| TwentyFour Income Fund Ltd | 192.69m | 181.91m | 1.03bn | 0.00 | 5.80 | 0.9726 | -- | 5.33 | 0.1824 | 0.1824 | 0.1933 | 1.09 | 0.1784 | -- | 16.08 | -- | 16.84 | 6.36 | 17.68 | 6.73 | 95.07 | 88.41 | 94.40 | 86.63 | -- | -- | 0.017 | 114.26 | 1,094.43 | 65.22 | 701.96 | 81.17 | -- | 9.15 |
| Molten Ventures PLC | -63.93m | -54.30m | 1.03bn | 55.00 | -- | 0.6182 | -- | -- | -0.3315 | -0.3315 | -0.2529 | 6.62 | -0.0357 | -- | -- | -869,090.90 | -3.03 | 5.83 | -3.05 | 5.88 | -- | -- | -- | 76.02 | -- | -7.00 | 0.0667 | 0.00 | 78.01 | -- | 83.32 | -- | -- | -- |
| ICG Enterprise Trust PLC | 58.09m | 23.23m | 1.03bn | 0.00 | 44.31 | 0.6274 | -- | 17.74 | 0.2704 | 0.2704 | 0.6685 | 19.09 | 0.0324 | -- | 18.59 | -- | 1.30 | 12.51 | 1.34 | 12.74 | 52.85 | 91.07 | 39.98 | 87.48 | -- | -- | 0.0154 | 14.09 | -76.87 | -14.06 | -89.44 | -26.65 | -- | 8.45 |
| NB Private Equity Partners Ltd | 15.88m | -22.14m | 1.04bn | -- | -- | 0.7827 | -- | 65.19 | -0.3551 | -0.3551 | 0.256 | 20.84 | 0.0108 | -- | -- | -- | -1.51 | 9.54 | -1.52 | 9.70 | -66.08 | 87.14 | -139.38 | 72.89 | -- | -- | 0.1172 | 28.63 | 191.67 | -2.40 | 124.85 | -10.29 | -- | 10.91 |
| Biopharma Credit PLC | 136.36m | 109.36m | 1.05bn | 11.00 | 10.46 | 0.8974 | -- | 7.73 | 0.0865 | 0.0865 | 0.107 | 1.01 | 0.1063 | -- | 3.57 | 12,396,270.00 | 8.53 | 8.48 | 8.56 | 8.57 | 81.85 | 83.12 | 80.20 | 81.71 | -- | -- | 0.00 | 98.44 | -37.78 | 6.89 | -40.51 | 9.11 | -- | 11.38 |
| Patria Private Equity Trust PLC | 93.45m | 65.36m | 1.08bn | 0.00 | 16.93 | 0.6855 | -- | 11.56 | 0.3179 | 0.3179 | 0.4545 | 7.85 | 0.0533 | -- | 527.35 | -- | 3.73 | 13.46 | 4.10 | 13.89 | 72.84 | 92.99 | 69.94 | 90.83 | -- | -- | 0.1012 | 16.84 | -49.35 | -2.36 | -57.55 | -5.55 | -- | 5.23 |
| Octopus Titan VCT PLC | -161.30m | -199.95m | 1.10bn | 0.00 | -- | 0.8114 | -- | -- | -0.0999 | -0.0999 | -0.0801 | 0.6236 | -0.1154 | -- | -- | -- | -14.30 | -- | -14.62 | -- | -- | -- | -- | -- | -- | -95.58 | 0.00 | -- | 59.28 | -- | 53.17 | -- | -- | -- |
| Merchants Trust plc | -26.23m | -40.46m | 1.15bn | 0.00 | -- | 1.11 | -- | -- | -0.2088 | -0.2088 | -0.1345 | 5.31 | -0.0215 | -- | -- | -- | -3.32 | 5.65 | -3.49 | 5.88 | -- | 82.97 | -- | 80.36 | -- | -- | 0.0783 | 80.57 | -140.19 | -- | -175.27 | -- | -- | 7.92 |
| CMC Markets Plc | 445.08m | 62.71m | 1.15bn | 1.17k | 18.80 | 2.18 | 13.91 | 2.59 | 0.167 | 0.167 | 1.19 | 1.44 | 0.5107 | -- | 1.00 | 285,650.70 | 7.20 | 15.21 | 11.64 | 23.55 | 98.71 | 98.12 | 14.09 | 27.15 | -- | 34.87 | 0.0402 | 50.06 | 15.38 | 20.53 | 13.14 | 51.48 | 24.25 | 32.53 |
| Fidelity China Special Situations PLC | -231.64m | -285.50m | 1.16bn | 0.00 | -- | 0.9566 | -- | -- | -0.4433 | -0.4433 | -0.3602 | 2.24 | -0.1296 | -- | -- | -- | -15.97 | -0.4496 | -16.98 | -0.4769 | -- | -17.97 | -- | -30.16 | -- | -- | 0.0107 | -- | -408.78 | -- | -1,016.59 | -- | -- | 10.70 |
| Oakley Capital Investments Ltd | 131.68m | 117.74m | 1.16bn | 0.00 | 10.14 | 0.7147 | -- | 8.83 | 0.499 | 0.499 | 0.5581 | 7.08 | 0.0753 | -- | 123.30 | -- | 6.73 | 16.71 | 7.28 | 16.84 | -- | -- | 89.41 | 94.21 | -- | 47.48 | 0.0882 | 4.51 | -75.18 | -8.38 | -78.70 | -10.35 | -- | 0.00 |
| Holder | Shares | % Held |
|---|---|---|
| Newton Investment Management Ltd.as of 31 Dec 2023 | 136.38m | 11.19% |
| Adage Capital Management LPas of 31 Dec 2023 | 130.85m | 10.73% |
| Sarasin & Partners LLPas of 07 May 2024 | 70.48m | 5.78% |
| M&G Investment Management Ltd.as of 31 Dec 2023 | 67.22m | 5.51% |
| FIL Investments Internationalas of 01 Jun 2024 | 28.73m | 2.36% |
| JPMorgan Chase Bank, NA (Investment Management)as of 01 Jun 2024 | 27.66m | 2.27% |
| Credit Suisse Asset Management (Schweiz) AGas of 01 Jun 2024 | 24.31m | 1.99% |
| abrdn, Inc.as of 29 Mar 2024 | 18.31m | 1.50% |
| Evelyn Partners Investment Management LLPas of 01 Jun 2024 | 17.81m | 1.46% |
| Morgan Stanley Smith Barney LLC (Investment Management)as of 01 Jun 2024 | 17.44m | 1.43% |
